Project Details
Description
A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/18 → 4/30/23 |
Funding
- EISAI MEDICAL RESEARCH INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.